Skip to main content
. 2021 May 11;373:n991. doi: 10.1136/bmj.n991

Table 2.

Efficacy outcomes in patients undergoing rhythm or rate control

Outcome Rhythm control Rate control Absolute rate difference per 100 person years*
(95% CI)
Weighted hazard ratio (95% CI) P value
No of events Person years Event rate* No of events Person years Event rate*
Early treatment of atrial fibrillation (≤1 year since the first diagnosis; rhythm control n=9246, rate control n=7077):
 Primary composite outcome 1187 19 461 7.42 1366 14 354 9.25 −1.82 (−2.91 to −0.73) 0.81 (0.71 to 0.93) 0.002
 Components of primary outcome
 Cardiovascular death 327 20 742 2.12 404 15 905 2.30 −0.18 (−0.72 to 0.36) 0.93 (0.73 to 1.19) 0.56
 Ischaemic stroke 469 20 165 2.70 543 15 234 3.69 −1.00 (−1.65 to −0.34) 0.74 (0.60 to 0.91) 0.004
 Admission to hospital for heart failure 541 20 030 3.33 689 14 976 4.27 −0.94 (−1.66 to −0.22) 0.79 (0.65 to 0.96) 0.02
 Acute myocardial infarction 52 20 685 0.23 51 15 841 0.39 −0.16 (−0.36 to 0.04) 0.59 (0.30 to 1.16) 0.13
 Nights spent in hospital/year† 26.1 (66.2) 30.4 (72.7) −4.2 (−6.4 to −2.1) <0.001
Late treatment of atrial fibrillation (>1 year since the first diagnosis; rhythm control n=4407, rate control n=1905):
 Primary composite outcome 691 9602 8.67 373 3926 8.99 −0.32 (−2.19 to 1.54) 0.97 (0.78 to 1.20) 0.76
 Components of primary outcome
 Cardiovascular death 196 10 407 2.46 128 4348 2.77 −0.31 (−1.28 to 0.66) 0.89 (0.61 to 1.29) 0.53
 Ischaemic stroke 246 10 063 3.13 161 4144 3.54 −0.41 (−1.53 to 0.71) 0.89 (0.63 to 1.24) 0.49
 Admission to hospital for heart failure 380 9926 4.24 167 4122 3.89 0.36 (−0.88 to 1.60) 1.10 (0.91 to 1.50) 0.53
 Acute myocardial infarction 26 10 382 0.23 13 4332 0.28 −0.06 (−0.36 to 0.25) 0.81 (0.25 to 2.66) 0.73
 Nights spent in hospital/year† 29.3 (70.9) 30.3 (72.4) −1.0 (−4.9 to 2.8) 0.60
*

Weighted incidence rate (per 100 person years) comparing rhythm and rate controlled patients after overlap weighting was applied.

Results are reported as mean (standard deviation) and the difference between the treatment groups was estimated using a two sample weighted t test.